🟢 Ardelyx is trading 6.77% up today after near break-even earnings beat loss expectations

Ardelyx is trading at $3.23, up 6.77%, after near break-even earnings beat expectations for a loss.

• The November 3 report showed IBSRELA sales up 23% year over year to $96.3 million.
• Management reaffirmed 2026 product revenue guidance and its 2027 profitability target.
• Revenue estimates are mixed: supplied context says a miss, while some published reports describe revenue above estimates. XBI rose 2.13%, potentially supporting the biotech-sector move.